Fertility and Subfertility Flashcards

1
Q

Define subfertility.

A

Failure to conceive after one year of regular unprotected sex

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

How do we categorise subfertility?

A

Primary: no previous pregnancies
Secondary: Previous pregnancy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What are the causes of subfertility?

A

15% Idiopathic

Female (50%): tubal disease, anovulatory (PCOS etc.), endometriosis, uterine factors (asherman’s)

Male (35%): chromosomal abnormality, endocrine causes, drugs, irradiation, infection (mumps/STI)

Sperm problems (30%)
Ovulation problems (25%)
Tubal problems (15%)
Uterine problems (10%)
Unexplained (20%)
40% of infertile couples have a mix of male and female causes.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

How common is subfertility?

A

10-15% of couples of reproductive age.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What are the RFs of subfertility?

A

smoking, alcohol, weed, excess exercise, extremes of body weight, female age, PID, ruptured appendix

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What are the conditions for pregnancy?

A
  1. Egg must be produced
  2. Adequate sperm must be released
  3. Sperm must reach the egg
  4. The egg must implant
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Describe the physiology of ovulation.

A

 Low oestrogen → positive feedback at hypothalamus → GnRH release pulses
 FSH and LH produced in response
 Leads to growth and initiates maturation of several follicles of the ovary, each of which contains an immature oocyte
 Follicles produce oestradiol → negative feedback on hypothalamus → low FSH/LH
 Dominant follicle has sufficient gonadotrophin receptors to survive
o Produces inhibin b → suppresses FSH
 High Oestadiol output → threshold potential reached → LH surge
 Rupture of follicle at 2cm diameter
 Egg collected by fallopian tube fimbriae
 Follicle → Corpus Luteum → progesterone production → secretory endometrium
 No implantationinvolution of CL→fall of progesterone
 Menstruation at 14 days after ovulation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

How do we detect of ovulation?

A

Hx

o Vast majority of women with regular cycles are ovulatory

o Vaginal spotting, increase VD or pelvic pain (‘mittelschmertz’) around time of ovulation

Ex

o Cervical mucus preovulation = acellular, will ‘fern’ when on a dry slide and form ‘spinbarkeit’ = elastic-like strings up to 15cm

o Body temperature drops 0.2c preovulation and rises 0.5c in the luteal phase

o Pattern can be seen on a temperature chart

Ix

Only proof of ovulation = conception
Elevated serum progesterone in mid-luteal phase indicates ovulation

o Low progesterone shows lack of ovulation if taken 7 days before subsequent menstruation (day 21 of 28)

o For women with irregular cycles, repeat progesterone may be required until menstruation starts

Ultrasound scans
o Monitor follicular growth
o Demonstrate fall in size and haemorrhagic nature of CL after ovulation

OTC urine predictor kits will indicate if LH surge has taken place

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Define PCOS.

A

Polycystic ovarian syndrome (PCOS) is a common condition causing metabolic and reproductive problems in women. There are characteristic features of multiple ovarian cysts, infertility, oligomenorrhea, hyperandrogenism and insulin resistance.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

How do we diagnose PCOS?

A

The Rotterdam criteria are used for making a diagnosis of polycystic ovarian syndrome. A diagnosis requires at least two of the three key features:

  • Oligoovulation or anovulation, presenting with irregular or absent menstrual periods - (>12 follicles in one ovary or ovarian volume >10ml)
  • Hyperandrogenism, characterised by hirsutism and acne
  • Polycystic ovaries on ultrasound (or ovarian volume of more than 10cm3)

Diagnosis of exclusions: exclude late onset CAH, Cushing’s, ovarian and adrenal neoplasms, hyperprolactinaemia, hypothyroidism

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Describe the presentations of PCOS?

A
  • Oligomenorrhoea or amenorrhoea
  • Infertility
  • Obesity (in about 70% of patients with PCOS)
  • Hirsutism
  • Acne
  • Hair loss in a male pattern

Presentation: 15-35 y.o. HAIR-AN – Hirsutism, hyper androgenism, infertility (also oligomenorrhoea, amenorrhoea), insulin resistance, acanthosis nigricans

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Describe the aetiology of PCOS? What are the RFs?

A
  • Aetiology: FHx, LH and hyperinsulinemia cause increased ovarian androgen production
  • RF: FHx, obesity, insulin resistance, HT, AI thyroid disease
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What are the complications and other features of PCOS?

A

In addition to the presenting features, women may also experience:

  • Insulin resistance and diabetes
  • Acanthosis nigricans
  • Cardiovascular disease
  • Hypercholesterolaemia
  • Endometrial hyperplasia and cancer
  • Obstructive sleep apnoea
  • Depression and anxiety
  • Sexual problems

Acanthosis nigricans describes thickened, rough skin, typically found in the axilla and on the elbows. It has a velvety texture. It occurs with insulin resistance.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What is the differential diagnosis of hirsutism?

A

An important feature of polycystic ovarian syndrome is hirsutism. Hirsutism can also be caused by:

  • Medications, such as phenytoin, ciclosporin, corticosteroids, testosterone and anabolic steroids
  • Ovarian or adrenal tumours that secrete androgens
  • Cushing’s syndrome
  • Congenital adrenal hyperplasia
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What role does insulin resistance have in PCOS?

A
  • Insulin resistance is a crucial part of PCOS. When someone is resistant to insulin, their pancreas has to produce more insulin to get a response from the cells of the body.
  • Insulin promotes the release of androgens from the ovaries and adrenal glands. Therefore, higher levels of insulin result in higher levels of androgens (such as testosterone).
  • Insulin also suppresses sex hormone-binding globulin (SHBG) production by the liver. SHBG normally binds to androgens and suppresses their function.
  • Reduced SHBG further promotes hyperandrogenism in women with PCOS.

The high insulin levels contribute to halting the development of the follicles in the ovaries, leading to anovulation and multiple partially developed follicles (seen as polycystic ovaries on the scan).

Diet, exercise and weight loss help reduce insulin resistance.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What are the investigations for PCOS?

A

The NICE clinical knowledge summaries recommend the following blood tests to diagnose PCOS and exclude other pathology that may have a similar presentation:

  • Testosterone
  • Sex hormone-binding globulin
  • Luteinizing hormone
  • Follicle-stimulating hormone
  • Prolactin (may be mildly elevated in PCOS)
  • Thyroid-stimulating hormone

Hormonal blood tests typically show:

  • Raised luteinising hormone
  • Raised LH to FSH ratio (high LH compared with FSH)
  • Raised testosterone
  • Raised insulin
  • Normal or raised oestrogen levels

OGTT

Imaging

  • USS pelvis:
    • 12 or more follicles in at least one ovary (measuring 2-9mm)
    • Increased ovarian volume (>10cm3)
    • In women starting cyclical progestogen due to prolonged amenorrhoea/AUB/excess weight, only do TVUSS to assess endometrial thickness after first withdrawal bleed
    • The follicles may be arranged around the periphery of the ovary, giving a “string of pearls” appearance.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

How do we interpret the results of the OGTT?

A
  • Fasting glucose 6.1-6.9 mol/L - impaired fasting glucose
  • 2-hour glucose 7.8-11.1 = IGT
  • >11.1 = DM
  • If OGTT shows impaired glucose tolerance: Annual OGTT
  • If OGTT normal: Annual random fasting glucose
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

How do we think about managing PCOS?

A
  • General management
  • Manage risk of endometrial cancer
  • Manage infertility
  • Manage hirtuisim
  • Manage acne
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

What is the general management of PCOS?

A

It is crucial to reduce the risks associated with obesity, type 2 diabetes, hypercholesterolaemia and cardiovascular disease. These risks can be reduced by:

  • Weight loss
  • Low glycaemic index, calorie-controlled diet
  • Exercise
  • Smoking cessation
  • Antihypertensive medications where required
  • Statins where indicated (QRISK >10%)

Patients should be assessed and managed for the associated features and complications, such as:

  • Endometrial hyperplasia and cancer
  • Infertility
  • Hirsutism
  • Acne
  • Obstructive sleep apnoea
  • Depression and anxiety

Weight loss is a significant part of the management of PCOS. Weight loss alone can result in ovulation and restore fertility and regular menstruation, improve insulin resistance, reduce hirsutism and reduce the risks of associated conditions.

Orlistat may be used to help weight loss in women with a BMI above 30. Orlistat is a lipase inhibitor that stops the absorption of fat in the intestines.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

What can be given to resolve the oligomenorrhea/amenorrhea?

A

COCP or Cyclical oral progesterone – if amenorrhoea/dysfunctional uterine bleeding
• This increases sex hormone-binding globulin which helps relieve androgenic symptoms

o Regulates the withdrawal bleed (should take place at least every 3-4months)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

How do we manage the risk of endometrial cancer in PCOS?

A

Women with polycystic ovarian syndrome have several risk factors for endometrial cancer:

  • Obesity
  • Diabetes
  • Insulin resistance
  • Amenorrhoea

Options for reducing the risk of endometrial hyperplasia and endometrial cancer are:

  • Mirena coil for continuous endometrial protection
  • Inducing a withdrawal bleed at least every 3 – 4 months with either:
    • Cyclical progestogens (e.g. medroxyprogesterone acetate 10mg once a day for 14 days)
    • Combined oral contraceptive pill
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

Why are patients with PCOS at higher risk of endometrial cancer?

A

Under normal circumstances, the corpus luteum releases progesterone after ovulation. Women with PCOS do not ovulate (or ovulate infrequently), and therefore do not produce sufficient progesterone. They continue to produce oestrogen and do not experience regular menstruation. Consequently, the endometrial lining continues to proliferate under the influence of oestrogen, without regular shedding during menstruation. This is similar to giving unopposed oestrogen in women on hormone replacement therapy. It results in endometrial hyperplasia and a significant risk of endometrial cancer.

Women with extended gaps between periods (more than three months) or abnormal bleeding need to be investigated with a pelvic ultrasound to assess the endometrial thickness. Cyclical progestogens should be used to induce a period prior to the ultrasound scan. If the endometrial thickness is more than 10mm, they need to be referred for a biopsy to exclude endometrial hyperplasia or cancer.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

How can we among infertility?

A

Weight loss is the initial step for improving fertility. Losing weight can restore regular ovulation.

A specialist may initiate other options where weight loss fails. These include:

  • Clomifene
  • Laparoscopic ovarian drilling
  • In vitro fertilisation (IVF)

Metformin and letrozole may also help restore ovulation under the guidance of a specialist; however, the evidence to support their use is not clear.

Ovarian drilling involves laparoscopic surgery. The surgeon punctures multiple holes in the ovaries using diathermy or laser therapy. This can improve the woman’s hormonal profile and result in regular ovulation and fertility.

Women that become pregnant require screening for gestational diabetes. Screening involves an oral glucose tolerance test, performed before pregnancy and at 24 – 28 weeks gestation.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

How can we manage hirsutism in PCOS?

A

Weight loss may improve the symptoms of hirsutism. Women are likely to have already explored options for hair removal, such as waxing, shaving and plucking.

Co-cyprindiol (Dianette) is a combined oral contraceptive pill licensed for the treatment of hirsutism and acne.

It has an anti-androgenic effect, works as a contraceptive and will also regulate periods. The downside is a significantly increased risk of venous thromboembolism. For this reason, co-cyprindiol is usually stopped after three months of use.

Topical eflornithine can be used to treat facial hirsutism. It usually takes 6 – 8 weeks to see a significant improvement. The hirsutism will return within two months of stopping eflornithine.

Other options that may be considered by a specialist experienced in treating hirsutism include:

  • Electrolysis
  • Laser hair removal
  • Spironolactone (mineralocorticoid antagonist with anti-androgen effects)
  • Finasteride (5α-reductase inhibitor that decreases testosterone production)
  • Flutamide (non-steroidal anti-androgen)
  • Cyproterone acetate (anti-androgen and progestin)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

How do we manage acne in PCOS??

A

The combined oral contraceptive pill is first-line for acne in PCOS. Co-cyprindiol may be the best option as it has anti-androgen effects; however, there is a significantly increased risk of venous thromboembolism.

Other standard treatments for acne include:

  • Topical adapalene (a retinoid)
  • Topical antibiotics (e.g. clindamycin 1% with benzoyl peroxide 5%)
  • Topical azelaic acid 20%
  • Oral tetracycline antibiotics (e.g. lymecycline)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
26
Q

How should we counsel a patient on PCOS?

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
27
Q

Summarise the management of PCOS.

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
28
Q

How do we split up the causes of anovulation?

A
  • Hypothalamic
  • Pituitary
  • Ovarian
  • Other
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
29
Q

What are the hypothalamic causes of anovulation?

A

Hypothalamic hypogonadism

o Low GnRH → FSH/LH → No ovulation

o Associated with anorexia, diets, athletes and those under stress

Kallmann’s syndrome

o GnRH secreting neurones fail to develop

o GnRH pump induces ovulation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
30
Q

What are the pituitary causes of anovulation?

A

Hyperprolactinaemia

o Excess prolactin → Low GnRH
o Tumours or pituitary hyperplasia
o Also associated with PCOS, hypothyroidism and use of psychotropic drugs o Accounts for 10% of anovulatory women
o Symptoms

  •  Oligomenorrhoea
  • Amenorrhoea
  • Galactorrhoea
  • Headaches
  • Bitemporal hemianopia

o CT imaging if neurological symptoms
o Tx with bromocriptine or cabergoline (dopamine agonists)

Pituitary damage
o Infarction = Sheehan’s syndrome

31
Q

What are the ovarian causes of anovulation?

A
  • Premature ovarian failure
  • Gonadal dysgenesis
  • Luteinised unruptured follicle syndrome

o Egg is never released

32
Q

What are the other causes of anovulation?

A

 Hypo- or hyperthyroidism

 Androgen secreting tumours

33
Q

What causes tubal damage?

A
  • PID - adhesions within the Fallopian tube
  • Endometriosis
  • Previous surgery/sterilisation - adhesions
34
Q

Apart from tubal damage what causes disorders in fertilisation in women?

A

 Cervical problems

o Rare
o Antibody production → agglutinate or kill sperm

o Infection →decrease mucus production
o Cone biopsy
o Use IUI to bypass cervix

 Sexual problems
o Psychological or organic

o Ignorance or discomfort can preent coitus

35
Q

What are the female investigations for subfertility?

A

Initial investigations, often performed in primary care:

  • Body mass index (BMI) (low could indicate anovulation, high could indicate PCOS)
  • Chlamydia screening
  • Female hormonal testing (see below)
  • Rubella immunity in the mother

Female hormone testing involves:

  • Serum LH and FSH on day 2 to 5 of the cycle
  • Serum progesterone on day 21 of the cycle (or 7 days before the end of the cycle if not a 28-day cycle).
  • Anti-Mullerian hormone
  • Thyroid function tests when symptoms are suggestive
  • Prolactin (hyperprolactinaemia is a cause of anovulation) when symptoms of galactorrhea or amenorrhoea

High FSH suggests poor ovarian reserve (the number of follicles that the woman has left in her ovaries). The pituitary gland is producing extra FSH in an attempt to stimulate follicular development.

High LH may suggest polycystic ovarian syndrome (PCOS).

A rise in progesterone on day 21 indicates that ovulation has occurred, and the corpus luteum has formed and started secreting progesterone.

Anti-Mullerian hormone can be measured at any time during the cycle and is the most accurate marker of ovarian reserve. It is released by the granulosa cells in the follicles and falls as the eggs are depleted. A high level indicates a good ovarian reserve.

Further investigations, often performed in secondary care:

  • Ultrasound pelvis to look for polycystic ovaries or any structural abnormalities in the uterus
  • Hysterosalpingogram to look at the patency of the fallopian tubes
  • Laparoscopy and dye test to look at the patency of the fallopian tubes, adhesions and endometriosis
36
Q

What is a hysterosalpingogram?

A

A hysterosalpingogram is a type of scan used to assess the shape of the uterus and the patency of the fallopian tubes. Not only does it help with diagnosis, but it also has therapeutic benefit. It seems to increase the rate of conception without any other intervention. Tubal cannulation under xray guidance can be performed during the procedure to open up the tubes.

A small tube is inserted into the cervix. A contrast medium is injected through the tube and fills the uterine cavity and fallopian tubes. Xray images are taken, and the contrast shows up on the xray giving an outline of the uterus and tubes. If the dye does not fill one of the tubes, this will be seen on an xray and suggests a tubal obstruction.

There is a risk of infection with the procedure, and often antibiotics are given prophylactically for patients with dilated tubes or a history of pelvic infection. Screening for chlamydia and gonorrhoea should be done before the procedure.

37
Q

What is the laparoscopy and dye test?

A

The patient is admitted for laparoscopy. During the procedure, dye is injected into the uterus and should be seen entering the fallopian tubes and spilling out at the ends of the tubes. This will not be seen when there is tubal obstruction. During laparoscopy, the surgeon can also assess for endometriosis or pelvic adhesions and treat these.

38
Q

How do we manage anovulation?

A

The options when anovulation is the cause of infertility include:

  • Weight loss for overweight patients with PCOS can restore ovulation
  • Clomifene may be used to stimulate ovulation
  • Letrozole may be used instead of clomifene to stimulate ovulation (aromatase inhibitor with anti-oestrogen effects)
  • Gonadotropins may be used to stimulate ovulation in women resistant to clomifene
  • Ovarian drilling may be used in polycystic ovarian syndrome
  • Metformin may be used when there is insulin insensitivity and obesity (usually associated with PCOS)
  1. Clomifene citrate 50 mg is an anti-oestrogen (a selective oestrogen receptor modulator). It is given on days 2 to 6 of the menstrual cycle. It stops the negative feedback of oestrogen on the hypothalamus, resulting in a greater release of GnRH and subsequently FSH and LH. - can use metformin alongside this
  2. Letrozole 2.5 mg (day 2-6) - aromatase inhibitor
  3. FSH and LH injections
  4. Ovarian drilling involves laparoscopic surgery. The surgeon punctures multiple holes in the ovaries using diathermy or laser therapy. This can improve the woman’s hormonal profile and result in regular ovulation and fertility.
39
Q

What are the side effects of ovulation induction?

A

 Multiple pregnancy

 Ovarian hyperstimluation syndrome

40
Q

Define ovarian hyperstimulation syndrome.

A

Ovarian hyperstimulation syndrome (OHSS) is a complication of ovarian stimulation during IVF infertility treatment. It is associated with the use of human chorionic gonadotropin (hCG) to mature the follicles during the final steps of ovarian stimulation.

41
Q

What is the pathophysiology of OHSS?

A

The primary mechanism for OHSS is an increase in vascular endothelial growth factor (VEGF) released by the granulosa cells of the follicles. VEGF increases vascular permeability, causing fluid to leak from capillaries. Fluid moves from the intravascular space to the extravascular space. This results in oedema, ascites and hypovolaemia.

The use of gonadotrophins (LH and FSH) during ovarian stimulation results in the development of multiple follicles. OHSS is provoked by the “trigger injection” of hCG 36 hours before oocyte collection. HCG stimulates the release of VEGF from the follicles. The features of the condition begin to develop after the hCG injection.

There is also activation of the renin-angiotensin system. A notable finding in patients with OHSS is a raised renin level. The renin level correlates with the severity of the condition.

42
Q

What are the RFs of OHSS?

A
  • Younger age
  • Lower BMI
  • Raised anti-Müllerian hormone
  • Higher antral follicle count
  • Polycystic ovarian syndrome
  • Raised oestrogen levels during ovarian stimulation
43
Q

How can we prevents OHSS?

A

Women are individually assessed for their risk of developing OHSS.

During stimulation with gonadotrophins, they are monitored with:

  • Serum oestrogen levels (higher levels indicate a higher risk)
  • Ultrasound monitor of the follicles (higher number and larger size indicate a higher risk)

In women at higher risk several strategies may be used to reduce the risk:

  • Use of the GnRH antagonist protocol (rather than the GnRH agonist protocol)
  • Lower doses of gonadotrophins
  • Lower dose of the hCG injection
  • Alternatives to the hCG injection (i.e. a GnRH agonist or LH)
44
Q

How does OHSS present?

A

Early OHSS presents within 7 days of the hCG injection. Late OHSS presents from 10 days onwards.

Features of the condition include:

  • Abdominal pain and bloating
  • Nausea and vomiting
  • Diarrhoea
  • Hypotension
  • Hypovolaemia
  • Ascites
  • Pleural effusions
  • Renal failure
  • Peritonitis from rupturing follicles releasing blood
  • Prothrombotic state (risk of DVT and PE)
45
Q

How do we assess severity of OHSS?

A

The severity is determined based on the clinical features:

  • Mild: Abdominal pain and bloating
  • Moderate: Nausea and vomiting with ascites seen on ultrasound
  • Severe: Ascites, low urine output (oliguria), low serum albumin, high potassium and raised haematocrit (>45%)
  • Critical: Tense ascites, no urine output (anuria), thromboembolism and acute respiratory distress syndrome (ARDS)
46
Q

What is the management of OHSS?

A

Management is supportive with treatment of any complications. This involves:

  • Oral fluids
  • Monitoring of urine output
  • Low molecular weight heparin (to prevent thromboembolism)
  • Ascitic fluid removal (paracentesis) if required
  • IV colloids (e.g. human albumin solution)
  • Termination of pregnancy to prevent further hormonal imbalances

Patients with mild to moderate OHSS are often managed as an outpatient. Severe cases require admission, and critical cases may require admission to the intensive care unit (ICU).

47
Q

When should a pt with OHSS be admitted tot hospital?

A
  • Unable to manage pain
  • Dehydration due to nausea
  • Worsening OHSS despite outpatient intervention
  • Unable to attend outpatient follow-up
  • Critical OHSS
48
Q

What are the complications of OHSS?

A
  • Hypovolaemic shock
  • Acute renal failure
  • VTE
49
Q

How do we manage tubal defects?

A

The options for women with alterations to the fallopian tubes that prevent the ovum from reaching the sperm and uterus include:

  • Tubal cannulation during a hysterosalpingogram
  • Laparoscopy to remove adhesions or endometriosis
  • In vitro fertilisation (IVF)
50
Q

What does IVF involve?

A

In vitro fertilisation involves fertilising an egg with sperm in a lab, then injecting the resulting embryo into the uterus. There are many steps along the way, and it is a complicated and expensive process. As a result, funding criteria are very strict and vary between areas. Couples are limited to a set number of cycles funded by the NHS.

Each attempt has a roughly 25 – 30% success rate at producing a live birth.

51
Q

What must be done before IVF?

A

Ovarian Reserve Testing (need to do this for IVF)

  • Age
  • Anti-Mullerian hormone (AMH)
    • (>25 is a good response)
  • FSH (the higher the less chance of success)
  • Antral follicle count
52
Q

Describe the process of IVF

A

A cycle of IVF involves a single episode of ovarian stimulation and collection of oocytes (eggs).

A single cycle may produce several embryos. Each of these embryos can be transferred separately in multiple attempts at pregnancy, all during one “cycle” of IVF.

Embryos that are not used immediately may be frozen to be used at a later date. Frozen embryos can potentially be used years later, even after a successful pregnancy.

Process

There are a number of steps involved in the process of IVF:

  • Suppressing the natural menstrual cycle - Involves GnRH agonist (goserelin) protocol - given during the luteal phase - usually day 21 → GnRH suppressed. Can also give GnRH antagonist daily SC injections (Cetrorelix) starting from day 5 - 6 of ovarian stimulation.
    • Prevent ovulation
    • Ensure ovaries respond correctly to gonadotrophins
  • Ovarian stimulation - involves using medications to promote the development of multiple follicles in the ovaries. This starts at the beginning of the menstrual cycle (usually day 2), with subcutaneous injections of follicle-stimulating hormone (FSH) over 10 to 14 days. he FSH stimulates the development of follicles, and this is closely monitored with regular transvaginal ultrasound scans.
    • When enough follicles have developed to an adequate size (usually around 18 millimetres), the FSH is stopped, and an injection of human chorionic gonadotropin (hCG) is given. This injection of HCG is given 36 hours before collection of the eggs. The hCG works similarly to LH does naturally, and stimulates the final maturation of the follicles, ready for collection. This is referred to as a “trigger injection”.
  • Oocyte collection
    • eggs are collected from the ovaries under the guidance of a transvaginal ultrasound scan. A needle is inserted through the vaginal wall into each ovary to aspirate the fluid from each follicle. This fluid contains the mature oocytes from the follicles. The procedure is usually performed under sedation (not a general anaesthetic). The fluid from the follicles is examined under the microscope for oocytes.
  • Insemination / intracytoplasmic sperm injection (ICSI)
    • The sperm and egg are mixed in a culture medium. Thousands of sperm need to be combined with each oocyte to produce enough enzymes (e.g. hyaluronic acid) for one sperm to penetrate the corona radiata and zona pellucida and fertilise the egg.
    • Intracytoplasmic Sperm Injection - a treatment used mainly for male factor infertility, where there are a reduced number or quality of sperm. It is an addition to the IVF process. After the eggs are harvested, and a semen sample is produced, the highest quality sperm are isolated and injected directly into the cytoplasm of the egg.
  • Embryo culture
    • Dishes containing the fertilised eggs are left in an incubator and observed over 2 – 5 days to see which will develop and grow. They are monitored until they reach the blastocyst stage of development (around day 5).
  • Embryo transfer
    • After 2 – 5 days, the highest quality embryos are selected for transfer. A catheter is inserted under ultrasound guidance through the cervix into the uterus. A single embryo is injected through the catheter into the uterus, and the catheter is removed. Generally, only a single embryo is transferred. Two embryos may be transferred in older women (i.e. over 35 years). Any remaining embryos can be frozen for future attempts at transfer.
  • Pregnancy
    • A pregnancy test is performed around day 16 after egg collection. When this is positive, implantation has occurred. Even after a positive test, there is still the possibility of miscarriage or ectopic pregnancy.
    • When the pregnancy test is negative, implantation has failed. At this point, hormonal treatment is stopped. The woman will go on to have a menstrual period. The bleeding may be more substantial than usual given the additional hormones used during ovarian stimulation.
    • Progesterone is used from the time of oocyte collection until 8 – 10 weeks gestation, usually in the form of vaginal suppositories. This is to mimic the progesterone that would be released by the corpus luteum during a typical pregnancy. From 8 – 10 weeks the placenta takes over production of progesterone, and the suppositories are stopped.
    • An ultrasound scan is performed early in the pregnancy (around 7 weeks) to check for a fetal heartbeat, and rule out miscarriage or ectopic pregnancy. When the ultrasound scan confirms a health pregnancy, the remainder of the pregnancy can proceed with standard care, as with any other pregnancy.
53
Q

What are the indications for IVF?

A
  • 6 cycles ovulation induction with clomifene +/- metformin/ ovarian drilling
  • Bilateral tube blockage
  • Unexplained after 2 years (3 years for others)
  • Same sex couples
  • Success calculator: age, previous cycles, parity, BMI
54
Q

What general advice should all women trying to conceive get?

A

There is some general lifestyle advice for couples trying to get pregnant:

  • The woman should be taking 400mcg folic acid daily
  • Aim for a healthy BMI
  • Avoid smoking and drinking excessive alcohol
  • Reduce stress as this may negatively affect libido and the relationship
  • Aim for intercourse every 2 – 3 days
  • Avoid timing intercourse
55
Q

What is the normal sperm count?

A

>15 million/Ml

56
Q

Define azoospermia.

A

no sperm

57
Q

Define oligospermia?.

A

<15 million/ml

58
Q

Define severe oligospermia.

A

<5 million/ml

59
Q

Define asthenospermia.

A

absent/low motility

60
Q

How are sperm samples provided?

A

Men should be given clear instructions for providing a sample:

  • Abstain from ejaculation for at least 3 days and at most 7 days
  • Avoid hot baths, sauna and tight underwear during the lead up to providing a sample
  • Attempt to catch the full sample
  • Deliver the sample to the lab within 1 hour of ejaculation
  • Keep the sample warm (e.g. in underwear) before delivery
61
Q

Describe Factors Affecting Semen Analysis and Sperm Quality and Quantity

A
  • Hot baths
  • Tight underwear
  • Smoking
  • Alcohol
  • Raised BMI
  • Caffeine

A repeat sample is indicated after 3 months in borderline results or earlier (2 – 4 weeks) with very abnormal results.

62
Q

Polyspermia

A

(or polyzoospermia) refers to a high number of sperm in the semen sample (more than 250 million per ml).

63
Q

Cryptozoospermia

A

refers to very few sperm in the semen sample (less than 1 million / ml).

64
Q

What results would you expect from sperm sample collection?

A

Normal results indicated by the World Health Organisation are:

  • Semen volume (more than 1.5ml)
  • Semen pH (greater than 7.2)
  • Concentration of sperm (more than 15 million per ml)
  • Total number of sperm (more than 39 million per sample)
  • Motility of sperm (more than 40% of sperm are mobile)
  • Vitality of sperm (more than 58% of sperm are active)
  • Percentage of normal sperm (more than 4%)
65
Q

What are the pre-testicular factors of infertility?

A

Testosterone is necessary for sperm creation. The hypothalamo-pituitary-gonadal axis controls testosterone. Hypogonadotrophic hypogonadism (low LH and FSH resulting in low testosterone), can be due to:

  • Pathology of the pituitary gland or hypothalamus
  • Suppression due to stress, chronic conditions or hyperprolactinaemia
  • Kallman syndrome
66
Q

What are the testicular causes of male factor fertility?

A

Testicular damage from:

  • Mumps
  • Undescended testes
  • Trauma
  • Radiotherapy
  • Chemotherapy
  • Cancer

Genetic or congenital disorders that result in defective or absent sperm production, such as:

  • Klinefelter syndrome
  • Y chromosome deletions
  • Sertoli cell-only syndrome
  • Anorchia (absent testes)
67
Q

What are the post-testicular causes of male factor infertility?

A

Obstruction preventing sperm being ejaculated can be caused by:

  • Damage to the testicle or vas deferens from trauma, surgery or cancer
  • Ejaculatory duct obstruction
  • Retrograde ejaculation
  • Scarring from epididymitis, for example, caused by chlamydia
  • Absence of the vas deferens (may be associated with cystic fibrosis)
  • Young’s syndrome (obstructive azoospermia, bronchiectasis and rhinosinusitis)
68
Q

What are the ix for male factor infertility?

A

Obstruction preventing sperm being ejaculated can be caused by:

  • Damage to the testicle or vas deferens from trauma, surgery or cancer
  • Ejaculatory duct obstruction
  • Retrograde ejaculation
  • Scarring from epididymitis, for example, caused by chlamydia
  • Absence of the vas deferens (may be associated with cystic fibrosis)
  • Young’s syndrome (obstructive azoospermia, bronchiectasis and rhinosinusitis)
69
Q

What are the ix for male factor infertility?

A

The initial steps for investigating abnormal semen analysis include a history, examination, repeat sample and ultrasound of the testes.

Patients with abnormal semen results are referred to a urologist for further investigations. Further investigations that may be considered include:

  • Hormonal analysis with LH, FSH and testosterone levels
  • Genetic testing
  • Further imaging, such as transrectal ultrasound or MRI
  • Vasography, which involves injecting contrast into the vas deferens and performing xray to assess for obstruction
  • Testicular biopsy
  • Semen analysis - Usually consists of 2 tests which are done 3 months apart
70
Q

How do we manage male factor infertility?

A

Management depends on the underlying cause, and can involve:

  • Surgical sperm retrieval where there is obstruction
  • Surgical correction of an obstruction in the vas deferens
  • Intra-uterine insemination involves separating high-quality sperm, then injecting them into the uterus
  • Intracytoplasmic sperm injection (ICSI) involves injecting sperm directly into the cytoplasm of an egg
  • Donor insemination involves sperm from a donor

If abnormal sperm:

  • Stop smoking, reduce alcohol and lose weight
  • Take multivitamins
  • Try for 70- 90 days and reassess

If still abnormal:

  • ICSI (intracytoplasmic sperm injection) - stick the sperm in the egg
  • May require specialist urological input
  • Should consider IUI (intrauterine insemination) or IVF after 2 years
  • If azoospermic and sperm not retrievable on testicular biopsy, counsel regarding donor
71
Q

Describe the process of intrauterine insemination.

A

Catheter passed through the cervix so is in lower part of uterine cavity, then injection sperm directly into uterine body to allow them to swim into fallopian tube

 Sperm is concentrated in the lab

 Sperm selected are more likely to be motile and morphologically normal

 Put sperm in usually 24h before ovulation is meant to occur or triggered to occur

 Used for unexplained infertility

IUI: 3 different ways

 Natural cycle

 Clomid: anti-oestrogen, fools pituitary to thinking oestrogen is low, triggers increased FSH production

 Gonadotrophin injections (superovulation/IUI)

 Risk of multiple pregnancy (15%)

Stimulated IUI

 2 or 3 eggs

 Give a trigger and give IUI 24h later

 Fertilisation occurs in vivo

72
Q

Summarise the management of subfertility.

A
73
Q

How do we counsel on subfertility’

A